Group 1 by Azwa Shamsuddin https://padlet.com/azwa_shamsuddin/jz47i1d7ekgzy1yl PRoTeCT stakeholders workshop en-us 2021-03-10 14:26:57 UTC 2021-03-23 11:14:43 UTC hello@padlet.com https://padlet-uploads.storage.googleapis.com/424009939/ade5173b14e4cecbdaf6dfb8f09f0dbb/PRoTeCT_logo.png G1Topic 1: What aspects of PINCER/OptimiseRx would be key to facilitate its use and engagement across groups of users (e.g. clinicians, managers, patients and carers, etc.) while maintaining a positive impact on safety? azwa_shamsuddin https://padlet.com/azwa_shamsuddin/jz47i1d7ekgzy1yl/wish/1293078595 PINCER - help with planning and prioritisation (generating caseloads), matching to clinical capacity (1).

Promoting collaboration, sharing learning across practices, involvement of all staff in training and implementation. Being able to share good practice. Show data to make difference at the end. Ability to predict reduction of patients at risk. Being able to make a difference. Picking up patients that may have otherwise been missed. Sustainable training that shares learning across practices (2).

The availability of a dataset to see reduction and changes made (3). Being able to see variances and why. 

Structure of PCNs more manageable than CCGs, enabling sharing across practices.

Continued availability of the indicators, infrastructure.

Patients - informing and involving patients in prescribing safety, emphasising monitoring and improving practice.


]]> 2021-03-10 14:28:09 UTC https://padlet.com/azwa_shamsuddin/jz47i1d7ekgzy1yl/wish/1293078595 G1Topic 2: What are the important considerations in taking a team approach across the healthcare system in implementing and sustaining PINCER/OptimiseRx for the longer-term? azwa_shamsuddin https://padlet.com/azwa_shamsuddin/jz47i1d7ekgzy1yl/wish/1293082675 Incentivising SMRs - to help identify patients at highest risk first. Consistent evidence-based approach to identify and manage patients. Making it more visible to policy makers and alignment to existing agendas (talking their language) (1).

Encourage CCGs to use PINCER as a tool to learn from each other and with PCNs (3). Learning at a local level, building relationships and friendly competitiveness.

Emphasising safety and quality as well as cost effectivesness.

Incentivising according to local priorities instead of blanket approach.

Training practices to work together to bring high risk patients to the forefront. High dose opiates as well as long term opiates. Long term risk reduction.

Emphasising PINCER and OptimiseRx complementing each other in enhancing safety (2), i.e. PINCER acting as safety net, OptimiseRx stopping patients being "PINCER patients".]]> 2021-03-10 14:28:43 UTC https://padlet.com/azwa_shamsuddin/jz47i1d7ekgzy1yl/wish/1293082675 G1Topic 3: How could engagement with secondary care be achieved for PINCER/OptimiseRx to ensure alignment of prescribing safety guidelines? azwa_shamsuddin https://padlet.com/azwa_shamsuddin/jz47i1d7ekgzy1yl/wish/1293131622 Communication between secondary and primary care needs improvement (2). Potential for missed communication due to business.

Gaps between primary and secondary care.

Alignment in local policies for both secondary and primary care (1).

Shared targets between primary and secondary care (3). NICE-level guidelines. Up-to-date national guidelines for all.


]]> 2021-03-10 14:36:38 UTC https://padlet.com/azwa_shamsuddin/jz47i1d7ekgzy1yl/wish/1293131622 Suggested agenda azwa_shamsuddin https://padlet.com/azwa_shamsuddin/jz47i1d7ekgzy1yl/wish/1341975033 You have a total of 50mins for the group task. We suggest you take the first 5mins to brainstorm ideas individually and then spend about 12mins discussing each topic which will make a total of approx. 35mins, leaving the final 10mins to select and rank 3 main points for each topic to share when we come back. 
Each group will have a researcher present to facilitate or answer any questions. 

]]> 2021-03-23 09:42:51 UTC https://padlet.com/azwa_shamsuddin/jz47i1d7ekgzy1yl/wish/1341975033